MapLight Therapeutics announced a $8.1 million grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF), to undertake a large-scale, systematic investigation of the brain circuits and mechanisms that are responsible for triggering ...
Amydis has received a new grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) for the Company’s pioneering retinal tracer program for alpha-synuclein (ASYN).
The Michael J. Fox Foundation for Parkinson's Research (MJFF) announces a milestone in the Foundation's impact on the Parkinson's disease (PD) therapeutic landscape.